Literature DB >> 12735556

Supraclavicular control of patent internal thoracic artery graft flow during aortic valve replacement.

Erkan Kuralay1, Faruk Cingöz, Celalettin Günay, Bilgehan Savaş Oz, Nezihi Küçükarslan, Vedat Yildirim, S Yavuz Sanisoglu, Ertuğrul Ozal, Ufuk Demirkiliç, Mehmet Arslan, Harun Tatar.   

Abstract

BACKGROUND: The mortality and morbidity of aortic valve replacement (AVR) after prior coronary artery bypass surgery (CABG) with patent left internal thoracic artery (LITA) is significant. The risk of LITA injury and inadequate myocardial preservation during the cross-clamp period may cause myocardial pump failure.
METHODS: A total of 43 patients with a patent LITA graft underwent AVR. The patients were divided into the two groups. Group 1 included 19 patients who underwent AVR with deep hypothermia (20 degrees C) without LITA clamping. Group 2 included 24 patients in whom LITA flow was controlled through supraclavicular occlusion and AVR performed with moderate hypothermia (28 degrees C).
RESULTS: Average cardiopulmonary bypass time (CPB) time was 118.79 +/- 20.36 minutes in group 1 and 102.67 +/- 9.66 minutes in group 2 (p = 0.006). Average cross-clamp time was 53.79 +/- 7.26 minutes in group 1 and 49.63 +/- 6.7 minutes in group 2 (p = 0.022). Inotropic support was required in 12 patients in group 1 and 4 patients in group 2 (p = 0.002). Average intensive care unit stay was 4.68 +/- 2.24 days in group 1 and 2.29 +/- 0.46 days in group 2 (p < 0.001). Average hospital stay was 11.84 +/- 2.91 days in group 1 and 8.04 +/- 2.38 days in group 2 (p < 0.001). Mortality due to myocardial failure developed in 4 patients in group 1 but in none of the patients in group 2 (p = 0.02).
CONCLUSIONS: Proximal control of LITA flow by extrathoracic supraclavicular occlusion reduces the incidence of myocardial failure due to nonhomogenous cardioplegia delivery to the anterior wall of the heart, resulting in improved myocardial protection and the elimination of the need for deep hypothermia.

Entities:  

Mesh:

Year:  2003        PMID: 12735556     DOI: 10.1016/s0003-4975(02)04989-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

1.  Aortic operation after previous coronary artery bypass grafting: management of patent grafts for myocardial protection.

Authors:  Masato Nakajima; Koji Tsuchiya; Shoji Fukuda; Hironobu Morimoto; Yoshitaka Mitsumori; Kaori Kato
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2006-04

2.  Myocardial protection during reoperative cardiac surgery: early experience with a new technique.

Authors:  Theodore Velissaris; Omar A Khan; Sanjay Asopa; Alison Calver; Sunil K Ohri
Journal:  Tex Heart Inst J       Date:  2010

3.  Aortic valve replacement for stenosis with or without coronary artery bypass grafting after 2 previous isolated coronary artery bypass grafting operations.

Authors:  Christopher Lee Henry; Jong Mi Ko; Albert Carl Henry; William Clifford Roberts; Gregory John Matter
Journal:  Proc (Bayl Univ Med Cent)       Date:  2011-01

4.  Feasibility and safety of continuous retrograde administration of Del Nido cardioplegia: a case series.

Authors:  Marc Najjar; Isaac George; Hirokazu Akashi; Takashi Nishimura; Halit Yerebakan; Linda Mongero; James Beck; Stephen C Hill; Hiroo Takayama; Mathew R Williams
Journal:  J Cardiothorac Surg       Date:  2015-11-26       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.